Incyte | Passivo Circulante



Current Liabilities Alterar Data
Acadia Pharmaceuticals USD 302.53M 92.34M 2025-03
Agios Pharmaceuticals USD 52.37M 28.79M 2025-03
Alnylam Pharmaceuticals USD 1.3B 225.22M 2025-06
Amgen USD 23.01B 91M 2025-03
Biogen USD 3.18B 2.11B 2025-06
BioMarin Pharmaceutical USD 628.21M 21.22M 2025-03
Bristol-Myers Squibb USD 27.53B 3.46B 2025-06
Eli Lilly USD 30.07B 1.69B 2025-03
Exelixis USD 336.11M 62.99M 2025-07
Gilead Sciences USD 12B 279M 2024-12
Incyte USD 1.28B 608.18M 2025-06
Ionis Pharmaceuticals USD 897.24M 646.94M 2025-06
MacroGenics USD 55.53M 3.78M 2024-12
Merck USD 25.17B 3.25B 2025-03
Moderna USD 1.6B 602M 2025-03
Neurocrine Biosciences USD 546.3M 23.4M 2025-06
Novartis USD 31.71B 95M 2025-06
Novartis USD 28.69B 560M 2024-12
Pfizer USD 36.45B 6.54B 2025-03
PTC Therapeutics USD 595.39M 14.41M 2025-03
Regeneron Pharmaceuticals USD 3.57B 2.13B 2025-03
Sarepta Therapeutics USD 605.59M 126.1M 2025-03
Ultragenyx Pharmaceutical USD 344.15M 59.14M 2024-12
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12


Incyte Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.